BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 932 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,401,870 | -15.5% | 116,637 | +2.1% | 0.08% | -12.5% |
| Q2 2023 | $5,206,646 | +12.2% | 114,281 | -0.1% | 0.09% | +3.5% |
| Q1 2023 | $4,640,028 | -16.1% | 114,399 | +5.4% | 0.08% | -19.8% |
| Q4 2022 | $5,532,328 | +60.5% | 108,541 | +69.6% | 0.11% | +34.2% |
| Q3 2022 | $3,446,000 | -3.4% | 63,987 | +15.2% | 0.08% | -1.2% |
| Q2 2022 | $3,568,000 | -18.1% | 55,549 | -1.2% | 0.08% | -5.9% |
| Q1 2022 | $4,358,000 | -0.7% | 56,198 | +9.9% | 0.08% | +2.4% |
| Q4 2021 | $4,389,000 | +1.5% | 51,134 | -4.9% | 0.08% | -4.6% |
| Q3 2021 | $4,324,000 | +5.0% | 53,759 | +5.1% | 0.09% | +4.8% |
| Q2 2021 | $4,117,000 | -3.9% | 51,147 | +0.7% | 0.08% | -11.7% |
| Q1 2021 | $4,284,000 | +29.8% | 50,798 | +23.5% | 0.09% | +23.7% |
| Q4 2020 | $3,301,000 | +3.4% | 41,136 | +3.6% | 0.08% | -3.8% |
| Q3 2020 | $3,192,000 | +213.6% | 39,692 | +235.7% | 0.08% | +192.6% |
| Q2 2020 | $1,018,000 | +6.2% | 11,825 | +0.1% | 0.03% | -18.2% |
| Q1 2020 | $959,000 | -3.2% | 11,810 | -0.3% | 0.03% | +22.2% |
| Q4 2019 | $991,000 | -9.7% | 11,847 | -5.6% | 0.03% | -18.2% |
| Q3 2019 | $1,098,000 | +2.2% | 12,547 | -4.3% | 0.03% | 0.0% |
| Q2 2019 | $1,074,000 | -4.4% | 13,109 | -5.2% | 0.03% | -5.7% |
| Q1 2019 | $1,124,000 | +0.9% | 13,824 | -18.3% | 0.04% | -14.6% |
| Q4 2018 | $1,114,000 | -20.6% | 16,929 | -7.0% | 0.04% | -6.8% |
| Q3 2018 | $1,403,000 | 0.0% | 18,202 | -4.2% | 0.04% | 0.0% |
| Q2 2018 | $1,403,000 | +8.7% | 18,995 | -4.3% | 0.04% | +15.8% |
| Q1 2018 | $1,291,000 | -15.2% | 19,846 | -15.7% | 0.04% | -20.8% |
| Q4 2017 | $1,522,000 | +1.0% | 23,547 | -1.9% | 0.05% | -2.0% |
| Q3 2017 | $1,507,000 | -15.7% | 24,005 | -18.7% | 0.05% | -18.3% |
| Q2 2017 | $1,788,000 | +60.2% | 29,529 | +37.3% | 0.06% | +57.9% |
| Q1 2017 | $1,116,000 | -11.1% | 21,514 | -24.1% | 0.04% | -11.6% |
| Q4 2016 | $1,256,000 | -10.7% | 28,332 | -4.1% | 0.04% | -15.7% |
| Q3 2016 | $1,406,000 | +2.0% | 29,554 | -3.0% | 0.05% | 0.0% |
| Q2 2016 | $1,378,000 | -4.4% | 30,482 | -13.1% | 0.05% | -5.6% |
| Q1 2016 | $1,441,000 | +5.7% | 35,095 | -1.8% | 0.05% | +5.9% |
| Q4 2015 | $1,363,000 | +13.8% | 35,727 | -2.0% | 0.05% | +6.2% |
| Q3 2015 | $1,198,000 | -93.4% | 36,453 | -86.0% | 0.05% | -92.9% |
| Q2 2015 | $18,217,000 | +3.6% | 260,501 | +1.5% | 0.68% | +3.0% |
| Q1 2015 | $17,576,000 | -3.6% | 256,587 | +3.1% | 0.66% | -6.1% |
| Q4 2014 | $18,239,000 | -25.8% | 248,852 | -27.3% | 0.70% | -29.5% |
| Q3 2014 | $24,583,000 | +0.8% | 342,524 | +1.5% | 0.99% | +1.0% |
| Q2 2014 | $24,392,000 | +3.5% | 337,367 | +5.3% | 0.98% | -2.9% |
| Q1 2014 | $23,565,000 | +11.2% | 320,271 | +5.1% | 1.01% | +7.8% |
| Q4 2013 | $21,200,000 | +27.1% | 304,820 | +20.0% | 0.94% | +14.9% |
| Q3 2013 | $16,680,000 | +7.1% | 253,911 | +13.0% | 0.82% | +0.1% |
| Q2 2013 | $15,568,000 | – | 224,744 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |